PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555689
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555689
Bone Glue Market size was valued at USD 2,478.32 million in 2023, expanding at a CAGR of 6.0% from 2024 to 2032.
The Bone Glue Market, encompassing adhesives used for bone repair and regeneration, is seeing growth due to advancements in orthopedic surgeries and an increase in the ageing population, which heightens the demand for bone-related treatments. Innovations in biocompatible materials, along with the rising incidence of osteoporosis and other bone-related conditions, are boosting market momentum. However, the market faces challenges, including stringent regulatory approvals and high costs associated with advanced bone adhesives. Nonetheless, opportunities exist in the form of increasing R&D investments and the expanding application of bone glue in minimally invasive surgeries. For instance, more than 200 million people globally suffer from osteoporosis, which underscores the potential for bone glue solutions in the coming years.
Bone Glue Market- Market Dynamics
Growing Geriatric Population Amplifying Demand for Bone Repair Solutions in the Bone Glue Market
The global increase in the ageing population is significantly driving the demand for bone repair solutions, including bone glue, in the healthcare sector. According to the World Health Organization (WHO), the number of people aged 60 years and older is expected to reach 2.1 billion by 2050, nearly doubling from 2020. This demographic shift is leading to a rise in age-related conditions such as osteoporosis and fractures, which require effective and reliable bone repair treatments. The National Osteoporosis Foundation reports that approximately 54 million Americans are affected by osteoporosis or low bone mass, further emphasizing the growing need for advanced bone repair products. As a result, healthcare providers are increasingly adopting bone glue as a minimally invasive alternative to traditional methods, offering improved patient outcomes and faster recovery times.
Bone Glue Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.0% over the forecast period (2024-2032)
Based on product type segmentation, Synthetic Bone Glue was predicted to show maximum market share in the year 2023
Based on material segmentation, Fibrin-Based Glue was the leading type in 2023
Based on formulation segmentation, Liquid Formulation was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Bone Glue Market is segmented based on Product Type, Material, Formulation, End-User, and Region.
The market is divided into two categories based on product type: Natural Bone Glue and Synthetic Bone Glue. Synthetic Bone Glue is prioritized due to its superior strength, consistency, and controlled degradation rates, making it more suitable for various surgical applications. Natural Bone Glue, while effective, is often prioritized less due to potential biocompatibility concerns.
The market is divided into four categories based on Material: Bovine Gelatin, Fibrin-Based Glue, Cyanoacrylate, and Polyurethane. Fibrin-based glue takes priority in the Bone Glue Market for its excellent biocompatibility and natural healing properties, followed by Cyanoacrylate for its strong adhesive capabilities. Polyurethane is next, valued for its flexibility, while Bovine Gelatin is prioritized lower due to potential allergenic risks.
Bone Glue Market- Geographical Insights
The Bone Glue Market exhibits varied growth across different geographical regions, with North America leading due to its advanced healthcare infrastructure, the high adoption rate of innovative medical technologies, and a significant ageing population. The presence of key market players and extensive R&D activities in the U.S. further strengthens the region's dominance. Europe follows closely, driven by an increasing prevalence of osteoporosis and supportive government healthcare initiatives. In Asia-Pacific, the market is growing rapidly, fueled by the expanding elderly population, rising healthcare expenditure, and increasing awareness about advanced bone repair treatments in countries like China and India. The region also benefits from a surge in medical tourism and the growing adoption of minimally invasive surgeries. Latin America and the Middle East & Africa, while still developing, are showing potential due to improving healthcare infrastructures and a rising focus on enhancing orthopedic care.
Major companies like CryoLife, Inc., Baxter International Inc., and Johnson & Johnson are at the forefront, leveraging their extensive R&D capabilities to introduce advanced bone adhesive solutions that cater to the growing demand for minimally invasive surgeries. These companies are also investing in expanding their product portfolios through mergers, acquisitions, and partnerships to strengthen their market position. Additionally, emerging players are entering the market with novel technologies and cost-effective solutions, aiming to capture market share in developing regions. The competition is further intensified by the need to meet stringent regulatory standards and obtain approvals from agencies such as the FDA and EMA, which adds pressure on manufacturers to ensure high-quality and safe products.
In December 2023, RevBio received FDA approval to initiate a first-in-human trial for its regenerative bone adhesive, Tetranite, aimed at cranial flap fixation. The 20-patient study will evaluate its safety and potential benefits over traditional metal plates and screws.
In July 2024, PBC BioVet, a new subsidiary of PBC Biomed, is launching a veterinary bone adhesive in August to simplify procedures and improve outcomes for veterinarians and their animal patients, aiming to drive positive change in the industry.